Variable | Grouping | Coefficient | OR | P-value |
---|---|---|---|---|
Sex | Male | Reference | Reference | Reference |
Female | −0.466 | 0.628 | 0.037 | |
Stage | I | Reference | Reference | Reference |
II | 0.744 | 2.105 | 0.161 | |
III | 1.573 | 4.823 | 0.006 | |
IV | 1.429 | 4.175 | 0.011 | |
IPI | Low | Reference | Reference | Reference |
Low-intermediate | 0.907 | 2.478 | 0.008 | |
High-intermediate | 0.953 | 2.594 | 0.013 | |
High | 1.210 | 3.352 | 0.016 | |
KPS | ≥ 80 | Reference | Reference | Reference |
<80 | 0.734 | 2.084 | 0.014 | |
GCB | No | Reference | Reference | Reference |
Yes | −0.792 | 0.453 | 0.041 | |
CD10 | Negative | Reference | Reference | Reference |
Positive | −1.144 | 0.318 | <  0.001 | |
Rituximab | Not use | Reference | Reference | Reference |
Use | −0.502 | 0.605 | 0.027 |